Asston Pharmaceuticals Limited (BOM:544445)

India · Delayed Price · Currency is INR

141.10

+2.30 (1.66%)

At close: Nov 6, 2026

Market Cap	1.54B +119.1%
Revenue (ttm)	254.69M +1.7%
Net Income	38.65M +0.3%
EPS	4.92 -20.0%
Shares Out	10.92M
PE Ratio	28.70
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,000
Open	136.50
Previous Close	138.80
Day's Range	134.00 - 144.95
52-Week Range	60.00 - 153.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Asston Pharmaceuticals

Asston Pharmaceuticals Limited manufactures pharmaceutical products in India, West Africa, South Africa, and Asian countries. The company provides tablets, such as aceclofenac, albendazole, aminophylline, artemether and lumefantrine, ascorbic acid chewable, azithromycin, b-complex, calcium, cholecalciferol with folic acid, cefixime, cetirizine, ciprofloxacin, co-trimoxazole, cyproheptadine, dexamethasone, diclofenac, ferrous sulphate, folic acid, glucose, griseofulvin, levofloxacin, loperamide HCL, losartan potassium, mebendazole, metformin hyd... [Read more]

Industry Pharmaceutical Preparations

Founded 2019

Employees 42

Stock Exchange Bombay Stock Exchange

Ticker Symbol 544445

Full Company Profile

Financial Performance

In fiscal year 2026, Asston Pharmaceuticals's revenue was 254.69 million, an increase of 1.72% compared to the previous year's 250.39 million. Earnings were 38.65 million, an increase of 0.32%.

Financial Statements